| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Joubin Jebelli, Michael C Hamper, Danielle Van Quelef, Davian Caraballo, James Hartmann, James Kumi-Diak. The Potential Therapeutic Effects of Low-Dose Ionizing Radiation in Alzheimer's Disease. Cureus. vol 14. issue 3. 2022-04-04. PMID:35371871. |
alzheimer's is classified as a progressive, debilitating neurodegenerative disease that results in disturbances to a patient's higher executive function, memory, language, and visuospatial orientation. |
2022-04-04 |
2023-08-13 |
Not clear |
| Katrina M Daigle, Malvina O Pietrzykowski, Abigail B Waters, Lance P Swenson, David A Gansle. Central Executive Network and Executive Function in Patients With Alzheimer's Disease and Healthy Individuals: Meta-Analysis of Structural and Functional MRI. The Journal of neuropsychiatry and clinical neurosciences. 2022-03-11. PMID:35272491. |
central executive network and executive function in patients with alzheimer's disease and healthy individuals: meta-analysis of structural and functional mri. |
2022-03-11 |
2023-08-13 |
Not clear |
| Daniel E Gustavson, Chandra A Reynolds, Timothy J Hohman, Angela L Jefferson, Jeremy A Elman, Matthew S Panizzon, Michael C Neale, Mark W Logue, Michael J Lyons, Carol E Franz, William S Kreme. Alzheimer's Disease Polygenic Scores Predict Changes in Episodic Memory and Executive Function Across 12 Years in Late Middle Age. Journal of the International Neuropsychological Society : JINS. 2022-02-21. PMID:35184795. |
alzheimer's disease polygenic scores predict changes in episodic memory and executive function across 12 years in late middle age. |
2022-02-21 |
2023-08-13 |
Not clear |
| Sogol Masoumzadeh, Zahra Moussav. Does Practicing with a Virtual Reality Driving Simulator Improve Spatial Cognition in Older Adults? A Pilot Study. Neuroscience insights. vol 15. 2022-02-17. PMID:35174332. |
memory, cognition, executive functioning, and spatial cognition loss are prevalent in the normal aging process, but these impairments are observed more extensively in individuals with dementia, specifically alzheimer's disease. |
2022-02-17 |
2023-08-13 |
human |
| Rickeem Butler, Sachin Jadhav, Kathleen E Rodger. Mechanisms of neuro- and cardioprotection of MAS agonists in the TAC model. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 17 Suppl 3. 2022-02-03. PMID:35109238. |
alzheimer's (ad) is a debilitating disease characterized by a loss of memory and executive function. |
2022-02-03 |
2023-08-13 |
mouse |
| Daniel E Gustavson, Chandra A Reynolds, Timothy J Hohman, Angela L Jefferson, Jeremy A Elman, Matthew S Panizzon, Michael J Lyons, Carol E Franz, William S Kreme. Alzheimer's disease polygenic scores predict changes in executive function across 12 years in late middle age. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 17 Suppl 3. 2022-02-03. PMID:35109378. |
alzheimer's disease polygenic scores predict changes in executive function across 12 years in late middle age. |
2022-02-03 |
2023-08-13 |
Not clear |
| Xianghong Arakaki, Shao-Min Hung, Roger Rochart, Alfred N Fonteh, Michael G Harringto. Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau. Neurobiology of aging. vol 112. 2022-01-23. PMID:35066324. |
synaptic dysfunctions precede cognitive decline in alzheimer's disease by decades, affect executive functions, and can be detected by quantitative electroencephalography (qeeg). |
2022-01-23 |
2023-08-13 |
human |
| Dawn Mechanic-Hamilton, Sean Lydon, Alex Miller, Kimberly Halberstadter, Michael DiCalogero, David A Wol. Development and pilot data for an app-based cognitive assessment for detecting memory and executive functioning changes in aging and pre-clinical AD. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 17 Suppl 11. 2021-12-31. PMID:34971050. |
this pilot study aims to determine the feasibility and psychometric properties of app-based memory and executive functioning tasks included in the mobile cognitive app performance platform (mcapp), to detect cognitive changes associated with aging and preclinical alzheimer's disease (ad). |
2021-12-31 |
2023-08-13 |
human |
| Shinichiro Maeshima, Aiko Osawa, Izumi Kondo, Masaki Kamiya, Ikue Ueda, Takashi Sakurai, Hidenori Ara. Differences in instrumental activities of daily living between mild cognitive impairment and Alzheimer's disease: A study using a detailed executive function assessment. Geriatrics & gerontology international. vol 21. issue 12. 2021-12-02. PMID:34643324. |
differences in instrumental activities of daily living between mild cognitive impairment and alzheimer's disease: a study using a detailed executive function assessment. |
2021-12-02 |
2023-08-13 |
Not clear |
| Tina Iachini, Francesco Ruotolo, Alessandro Iavarone, Michele Carpinelli Mazzi, Gennaro Ruggier. From aMCI to AD: The Role of Visuo-Spatial Memory Span and Executive Functions in Egocentric and Allocentric Spatial Impairments. Brain sciences. vol 11. issue 11. 2021-11-29. PMID:34827534. |
a difficulty in encoding spatial information in an egocentric (i.e., body-to-object) and especially allocentric (i.e., object-to-object) manner, and impairments in executive function (ef) are typical in amnestic mild cognitive impairment (amci) and alzheimer's disease (ad). |
2021-11-29 |
2023-08-13 |
human |
| Amy Shepherd, Jeremiah K H Lim, Vicky H Y Wong, Ariel M Zeleznikow-Johnston, Leonid Churilov, Christine T O Nguyen, Bang V Bui, Anthony J Hannan, Emma L Burrow. Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing. Neurobiology of aging. vol 108. 2021-11-24. PMID:34509856. |
progressive impairments in executive function in the app/ps1 model of alzheimer's disease as measured by translatable touchscreen testing. |
2021-11-24 |
2023-08-13 |
mouse |
| Amy Shepherd, Jeremiah K H Lim, Vicky H Y Wong, Ariel M Zeleznikow-Johnston, Leonid Churilov, Christine T O Nguyen, Bang V Bui, Anthony J Hannan, Emma L Burrow. Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing. Neurobiology of aging. vol 108. 2021-11-24. PMID:34509856. |
executive function deficits in alzheimer's disease (ad) occur early in disease progression and may be predictive of cognitive decline. |
2021-11-24 |
2023-08-13 |
mouse |
| Fanny Gaubert, Hanna Chaina. Decision-Making Competence in Patients with Alzheimer's Disease: A Review of the Literature. Neuropsychology review. vol 31. issue 2. 2021-10-28. PMID:33576942. |
in this review, we focus on dmc in patients with alzheimer's disease (ad) and the links its impairment could have with deficits in episodic memory, working memory, and executive functions. |
2021-10-28 |
2023-08-13 |
Not clear |
| Kirsty Lu, Keir X X Yong, Iwona Skorupinska, Stephanie Deriziotis, Jessica D Collins, Susie M D Henley, Michael G Hanna, Martin N Rossor, Basil H Ridha, Pedro M Machad. A cross-sectional study of memory and executive functions in patients with sporadic inclusion body myositis. Muscle & nerve. 2021-10-22. PMID:34605039. |
in this study we investigated whether cognitive performance of patients with ibm differs from population norms, focusing on cognitive domains affected in early alzheimer disease (memory, executive function), and to test whether disease duration and the level of disability of ibm are associated with cognitive function. |
2021-10-22 |
2023-08-13 |
Not clear |
| Brian Blum, Shivani Kaushal, Sara Khan, Jae H Kim, Clara L Alvarez Villalb. Melatonin in Traumatic Brain Injury and Cognition. Cureus. vol 13. issue 9. 2021-10-22. PMID:34659987. |
the devastating effects of tbi on emotion regulation, executive functioning, and cognition have been well-established, and recent research links tbi as a risk factor for neurodegenerative diseases such as alzheimer's disease. |
2021-10-22 |
2023-08-13 |
human |
| Daniel Kempler, Mira Gora. Language and Dementia: Neuropsychological Aspects. Annual review of applied linguistics. vol 28. 2021-10-20. PMID:21072322. |
a survey of data from investigations of three dementia syndromes (alzheimer's disease, semantic dementia and progressive nonfluent aphasia) reveals that, more often than not, deterioration of conceptual organization appears associated with lexical impairments, whereas impairments in executive function are associated with sentence- and discourse-level deficits. |
2021-10-20 |
2023-08-12 |
Not clear |
| Bárbara Duarte-Abritta, Stella-Maris Sánchez, Carolina Abulafia, Deborah R Gustafson, Silvia Vázquez, Gustavo Sevlever, Mariana N Castro, Leticia Fiorentini, Mirta F Villarreal, Salvador M Guinjoa. Amyloid and anatomical correlates of executive functioning in middle-aged offspring of patients with late-onset Alzheimer's disease. Psychiatry research. Neuroimaging. vol 316. 2021-10-14. PMID:34365076. |
amyloid and anatomical correlates of executive functioning in middle-aged offspring of patients with late-onset alzheimer's disease. |
2021-10-14 |
2023-08-13 |
human |
| Shubir Dutt, Yanrong Li, Mara Mather, Daniel A Natio. Brainstem substructures and cognition in prodromal Alzheimer's disease. Brain imaging and behavior. vol 15. issue 5. 2021-10-12. PMID:33646514. |
within mild cognitive impairment participants, smaller midbrain and locus coeruleus volumes were significantly related to poorer performance on tests of attention and executive function, and the relationship between locus coeruleus volume and executive abilities remained significant in the mild cognitive impairment subsample with biomarker-confirmed alzheimer's disease. |
2021-10-12 |
2023-08-13 |
human |
| Sharon Lam, Richard B Lipton, Danielle J Harvey, Andrea R Zammit, Ali Ezzat. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles. Journal of the American Geriatrics Society. vol 69. issue 7. 2021-10-11. PMID:33891712. |
to examine the association between white matter hyperintensities (wmh) and cognitive domains such as memory and executive function (ef) across different clinical and biomarker categories of alzheimer's disease (ad). |
2021-10-11 |
2023-08-13 |
Not clear |
| Robert Lillig, Anja Ophey, Jörg B Schulz, Kathrin Reetz, Jennifer Wojtala, Alexander Storch, Inga Liepelt-Scarfone, Sara Becker, Daniela Berg, Monika Balzer-Geldsetzer, Jan Kassubek, Rüdiger Hilker-Roggendorf, Karsten Witt, Brit Mollenhauer, Claudia Trenkwalder, Sandra Roeske, Hans-Ullrich Wittchen, Oliver Riedel, Richard Dodel, Elke Kalb. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Parkinsonism & related disorders. vol 90. 2021-10-11. PMID:34418761. |
the consortium to establish a registry for alzheimer's disease (cerad) is a renowned cognitive test battery, which has been extended in its german version to the cerad-plus including tests of executive functions and processing speed. |
2021-10-11 |
2023-08-13 |
Not clear |